JZP898
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JZP898, covering 2025-12-16 to 2025-12-16. Get the full timeline:
Most recent: Clinical Trial Update: JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors [Phase 1]